Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 3 catalytic subunit gamma (PPP3CC) is a catalytic subunit of the calcium- and calmodulin-dependent serine/threonine phosphatase known as calcineurin. This enzyme plays a crucial role in intracellular Ca^2+-mediated signal transduction by dephosphorylating key regulatory proteins and transcription factors, including NFAT and ELK1. PPP3CC is highly conserved across species and shows specific expression in the testis, where it is implicated in sperm motility regulation. Mutations or altered expression of PPP3CC have been associated with neuropsychiatric and developmental disorders. Calcineurin, including PPP3CC, is targeted by immunosuppressive drugs such as cyclosporine and tacrolimus, which block its phosphatase activity and thus inhibit downstream immune response signaling
Inhibition of calcineurin phosphatase activity, leading to suppression of NFAT-dependent transcription and downstream effects (notably T-cell activation suppression for immunosuppressive drugs)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 3 catalytic subunit gamma (PPP3CC).